Back
Pliant Therapeutics Vs. Marker Therapeutics Industry Stock Comparison
Buy
62
PLRX
Pliant Therapeutics
Last Price:
14.65
Seasonality Move:
0.63%
Buy
58
MRKR
Marker Therapeutics
Last Price:
4.49
Seasonality Move:
1.24%
Buy
62
Pliant Therapeutics (PLRX)
is a Buy
Is Pliant Therapeutics a Buy, Sell or Hold?
- The current Pliant Therapeutics [PLRX] share price is $14.63. The Score for PLRX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- PLRX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Marker Therapeutics (MRKR)
is a Buy
Is Marker Therapeutics a Buy, Sell or Hold?
- The current Marker Therapeutics [MRKR] share price is $4.54. The Score for MRKR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- MRKR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PLRX Stock Price Chart
What is Pliant Therapeutics's stock price today?
-
The Pliant Therapeutics share price today is $14.63
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLRX is experiencing slight buying pressure.
MRKR Stock Price Chart
What is Marker Therapeutics's stock price today?
-
The Marker Therapeutics share price today is $4.54
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRKR is experiencing slight buying pressure.
PLRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.7 | Buy |
| Relative Strength Index (14 RSI): | 65.21 | Buy |
| Chaikin Money Flow: | 88044 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.89 - 13.75) | Buy |
| Bollinger Bands (100): | (11.18 - 13.44) | Buy |
MRKR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 73.06 | Buy |
| Chaikin Money Flow: | 52777 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.49 - 3.41) | Buy |
| Bollinger Bands (100): | (2.93 - 4.81) | Buy |
PLRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.08 | Buy |
| 20-day SMA: | 12.35 | Buy |
| 50-day SMA: | 12.56 | Buy |
| 200-day SMA: | 13.77 | Buy |
| 8-day EMA: | 14.04 | Buy |
| 20-day EMA: | 13.06 | Buy |
| 50-day EMA: | 12.65 | Buy |
| 200-day EMA: | 13.72 | Buy |
MRKR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.39 | Buy |
| 20-day SMA: | 2.98 | Buy |
| 50-day SMA: | 3.13 | Buy |
| 200-day SMA: | 4.09 | Buy |
| 8-day EMA: | 3.56 | Buy |
| 20-day EMA: | 3.2 | Buy |
| 50-day EMA: | 3.29 | Buy |
| 200-day EMA: | 3.84 | Buy |
Pliant Therapeutics Earnings Growth & PLRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.32 per share.
Marker Therapeutics Earnings Growth & MRKR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.71 per share, and a decrease next year of $0.03 per share.
Pliant Therapeutics Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Marker Therapeutics Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||